Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415708
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-03-04
Brief Title:
Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China
Organization Data
Organization:
Institute of Hematology Blood Diseases Hospital China
Class:
OTHER
Study ID:
BDHBcell2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Hematology Blood Diseases Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None